These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association of AEBP1 and NRN1 RNA expression with Alzheimer's disease and neurofibrillary tangle density in middle temporal gyrus. Piras IS; Krate J; Delvaux E; Nolz J; De Both MD; Mastroeni DF; Serrano GE; Sue LI; Beach TG; Coleman PD; Huentelman MJ Brain Res; 2019 Sep; 1719():217-224. PubMed ID: 31176712 [TBL] [Abstract][Full Text] [Related]
3. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Hatanpää K; Brady DR; Stoll J; Rapoport SI; Chandrasekaran K Ann Neurol; 1996 Sep; 40(3):411-20. PubMed ID: 8797530 [TBL] [Abstract][Full Text] [Related]
4. Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer's disease. Chen S; Chang Y; Li L; Acosta D; Li Y; Guo Q; Wang C; Turkes E; Morrison C; Julian D; Hester ME; Scharre DW; Santiskulvong C; Song SX; Plummer JT; Serrano GE; Beach TG; Duff KE; Ma Q; Fu H Acta Neuropathol Commun; 2022 Dec; 10(1):188. PubMed ID: 36544231 [TBL] [Abstract][Full Text] [Related]
5. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ginsberg SD; Hemby SE; Lee VM; Eberwine JH; Trojanowski JQ Ann Neurol; 2000 Jul; 48(1):77-87. PubMed ID: 10894219 [TBL] [Abstract][Full Text] [Related]
6. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Luterman JD; Haroutunian V; Yemul S; Ho L; Purohit D; Aisen PS; Mohs R; Pasinetti GM Arch Neurol; 2000 Aug; 57(8):1153-60. PubMed ID: 10927795 [TBL] [Abstract][Full Text] [Related]
7. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease. Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871 [TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease. Joyce JN; Myers AJ; Gurevich E Brain Res; 1998 Feb; 784(1-2):7-17. PubMed ID: 9518532 [TBL] [Abstract][Full Text] [Related]
9. Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1. Li QS; De Muynck L Brain Behav Immun Health; 2021 May; 13():100227. PubMed ID: 34589742 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's brains show inter-related changes in RNA and lipid metabolism. Barbash S; Garfinkel BP; Maoz R; Simchovitz A; Nadorp B; Guffanti A; Bennett ER; Nadeau C; Türk A; Paul L; Reda T; Li Y; Buchman AS; Greenberg DS; Seitz A; Bennett DA; Giavalisco P; Soreq H Neurobiol Dis; 2017 Oct; 106():1-13. PubMed ID: 28630030 [TBL] [Abstract][Full Text] [Related]
19. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology. Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539 [TBL] [Abstract][Full Text] [Related]
20. Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology. Walker DG; Lue LF; Tang TM; Adler CH; Caviness JN; Sabbagh MN; Serrano GE; Sue LI; Beach TG Neurobiol Aging; 2017 Jun; 54():175-186. PubMed ID: 28390825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]